Knowledge Tree
Relations (1)
related 3.58 — strongly supporting 11 facts
Cognitive Behavioral Therapy is a primary therapeutic intervention evaluated for the treatment of anxiety-related disorders, as evidenced by its role in randomized controlled trials [1], [2] and meta-analyses [3], [4], [5] assessing its clinical efficacy and long-term outcomes [6], [7], [8].
Facts (11)
Sources
Efficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders link.springer.com 11 facts
referenceThe systematic review on the efficacy of Cognitive Behavioral Therapy for anxiety-related disorders is a continuation of previous works by Hofmann and Smits (2008) and Carpenter et al. (2018).
claimThe meta-analysis conducted by the authors aimed to update previous meta-analyses by Hofmann and Smits (2008) and Carpenter et al. (2018) regarding placebo-controlled trials of Cognitive Behavioral Therapy (CBT) for adults with anxiety-related disorders.
claimThe meta-analysis by van Dis et al. (2020) titled 'Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders' found that the effects of cognitive behavioral therapy (CBT) for anxiety-related disorders were unstable after 12 months of treatment.
claimThe updated analysis found no significant advantage of Cognitive Behavioral Therapy (CBT) over placebo on depression symptoms, either among PTSD studies or across all anxiety-related disorders.
measurementThe effects of Cognitive Behavioral Therapy (CBT) for anxiety-related disorders were found to be very small and not significant at the 6-month follow-up (Hedges’ g = 0.09, 95% CI − 0.08 to 0.28, p = n.s.).
measurementA meta-regression analysis found no significant association between the number of Cognitive Behavioral Therapy (CBT) sessions and the effect size on anxiety-related disorders (p = n.s.).
claimMeta-analyses comparing Cognitive Behavioral Therapy against placebo conditions find strong support for CBT as an efficacious intervention for anxiety-related disorders, though the effect sizes are more modest than those found in meta-analyses comparing CBT against waitlist controls.
procedureThe researchers searched PubMed, PsycINFO, and Web of Science for randomized controlled clinical trials published between January 1, 2017, and January 31, 2022, using search terms related to Cognitive Behavioral Therapy and various anxiety-related disorders, excluding studies on children.
procedureTo be included in the meta-analysis, studies had to meet four criteria: (1) patients were aged 18 to 65 and met DSM-III-R, DSM-IV, or DSM-5 diagnostic criteria for specific anxiety-related disorders; (2) patients were randomly assigned to either CBT or a placebo (pill or psychological); (3) anxiety symptom severity was assessed via a validated clinical interview or self-report instrument pre- and post-treatment; and (4) studies provided sufficient data to calculate effect sizes.
perspectiveThe authors of the 2020 JAMA Psychiatry meta-analysis on long-term outcomes of cognitive behavioral therapy for anxiety-related disorders suggest that future research should examine variables associated with treatment response to help optimize treatment.
referenceThe article titled 'Efficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Meta-Analysis of Recent Literature' was published in Current Psychiatry Reports, volume 25, pages 19–30, in 2023.